
Akm E. Ullah
Examiner (ID: 10221, Phone: (571)272-2361 , Office: P/2874 )
| Most Active Art Unit | 2874 |
| Art Unit(s) | 2874, 2606, 2501, 1734, 2899, 3621, 2838 |
| Total Applications | 3400 |
| Issued Applications | 3065 |
| Pending Applications | 95 |
| Abandoned Applications | 245 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 13554755
[patent_doc_number] => 20180328925
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-11-15
[patent_title] => MEMBRANE BOUND REPORTER MOLECULES AND THEIR USE IN CELL SORTING
[patent_app_type] => utility
[patent_app_number] => 15/975848
[patent_app_country] => US
[patent_app_date] => 2018-05-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13426
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -29
[patent_words_short_claim] => 47
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15975848
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/975848 | Membrane bound reporter molecules and their use in cell sorting | May 9, 2018 | Issued |
Array
(
[id] => 13387049
[patent_doc_number] => 20180245066
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-08-30
[patent_title] => sgRNA and knockout method of human RSPO2 gene targeted with CRISPR-Cas9 specificity and application thereof
[patent_app_type] => utility
[patent_app_number] => 15/961886
[patent_app_country] => US
[patent_app_date] => 2018-04-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5920
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 26
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15961886
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/961886 | sgRNA and knockout method of human RSPO2 gene targeted with CRISPR-Cas9 specificity and application thereof | Apr 24, 2018 | Abandoned |
Array
(
[id] => 13343651
[patent_doc_number] => 20180223365
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-08-09
[patent_title] => METHOD FOR SCREENING CANDIDATE COMPOUNDS FOR PREVENTING AND/OR ATTENUATING SKIN AGING, AND/OR FOR HYDRATING THE SKIN
[patent_app_type] => utility
[patent_app_number] => 15/947005
[patent_app_country] => US
[patent_app_date] => 2018-04-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6730
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -5
[patent_words_short_claim] => 93
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15947005
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/947005 | METHOD FOR SCREENING CANDIDATE COMPOUNDS FOR PREVENTING AND/OR ATTENUATING SKIN AGING, AND/OR FOR HYDRATING THE SKIN | Apr 5, 2018 | Abandoned |
Array
(
[id] => 19259018
[patent_doc_number] => 12019068
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-06-25
[patent_title] => Method for predicting therapeutic effect and/or recurrence monitoring in cancer patients
[patent_app_type] => utility
[patent_app_number] => 16/498895
[patent_app_country] => US
[patent_app_date] => 2018-03-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 4118
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 124
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16498895
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/498895 | Method for predicting therapeutic effect and/or recurrence monitoring in cancer patients | Mar 29, 2018 | Issued |
Array
(
[id] => 13987133
[patent_doc_number] => 20190062724
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-02-28
[patent_title] => RNA TARGETING METHODS AND COMPOSITIONS
[patent_app_type] => utility
[patent_app_number] => 15/937699
[patent_app_country] => US
[patent_app_date] => 2018-03-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 44170
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -23
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15937699
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/937699 | RNA targeting methods and compositions | Mar 26, 2018 | Issued |
Array
(
[id] => 13329129
[patent_doc_number] => 20180216102
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-08-02
[patent_title] => Methods for Obtaining Information from Single Cells Within Populations Using DNA Origami Nanostructures Without the Need for Single Cell Sorting
[patent_app_type] => utility
[patent_app_number] => 15/937371
[patent_app_country] => US
[patent_app_date] => 2018-03-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6209
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -1
[patent_words_short_claim] => 52
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15937371
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/937371 | Methods for obtaining information from single cells within populations using DNA origami nanostructures without the need for single cell sorting | Mar 26, 2018 | Issued |
Array
(
[id] => 18117528
[patent_doc_number] => 11548909
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-01-10
[patent_title] => Methods of using nucleotide analogues
[patent_app_type] => utility
[patent_app_number] => 15/928562
[patent_app_country] => US
[patent_app_date] => 2018-03-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 72
[patent_figures_cnt] => 89
[patent_no_of_words] => 31650
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 126
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15928562
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/928562 | Methods of using nucleotide analogues | Mar 21, 2018 | Issued |
Array
(
[id] => 13316917
[patent_doc_number] => 20180209996
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-07-26
[patent_title] => MARKER COMPOSITION COMPRISING S1P LIPID FOR PREDICTING RISK OF OSTEOPOROTIC FRACTURE AND OSTEOPOROSIS
[patent_app_type] => utility
[patent_app_number] => 15/927459
[patent_app_country] => US
[patent_app_date] => 2018-03-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4620
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -6
[patent_words_short_claim] => 34
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15927459
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/927459 | MARKER COMPOSITION COMPRISING S1P LIPID FOR PREDICTING RISK OF OSTEOPOROTIC FRACTURE AND OSTEOPOROSIS | Mar 20, 2018 | Abandoned |
Array
(
[id] => 13329127
[patent_doc_number] => 20180216101
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-08-02
[patent_title] => MICROBIAL STRAIN IMPROVEMENT BY A HTP GENOMIC ENGINEERING PLATFORM
[patent_app_type] => utility
[patent_app_number] => 15/923555
[patent_app_country] => US
[patent_app_date] => 2018-03-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 67009
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 338
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15923555
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/923555 | Microbial strain improvement by a HTP genomic engineering platform | Mar 15, 2018 | Issued |
Array
(
[id] => 13428783
[patent_doc_number] => 20180265934
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-09-20
[patent_title] => COINCIDENCE REPORTER GENE SYSTEM
[patent_app_type] => utility
[patent_app_number] => 15/916762
[patent_app_country] => US
[patent_app_date] => 2018-03-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17287
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -5
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15916762
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/916762 | COINCIDENCE REPORTER GENE SYSTEM | Mar 8, 2018 | Abandoned |
Array
(
[id] => 14732033
[patent_doc_number] => 10385407
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-08-20
[patent_title] => Method for screening induced pluripotent stem cells
[patent_app_type] => utility
[patent_app_number] => 15/909666
[patent_app_country] => US
[patent_app_date] => 2018-03-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 9803
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 59
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15909666
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/909666 | Method for screening induced pluripotent stem cells | Feb 28, 2018 | Issued |
Array
(
[id] => 15541261
[patent_doc_number] => 10570397
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-02-25
[patent_title] => Reduction of lipase activity in product formulations
[patent_app_type] => utility
[patent_app_number] => 15/897290
[patent_app_country] => US
[patent_app_date] => 2018-02-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 17
[patent_figures_cnt] => 17
[patent_no_of_words] => 15461
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 67
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15897290
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/897290 | Reduction of lipase activity in product formulations | Feb 14, 2018 | Issued |
Array
(
[id] => 13343549
[patent_doc_number] => 20180223314
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-08-09
[patent_title] => POTENT AND SHORT PROMOTER FOR EXPRESSION OF HETEROLOGOUS GENES
[patent_app_type] => utility
[patent_app_number] => 15/891986
[patent_app_country] => US
[patent_app_date] => 2018-02-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 24224
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -20
[patent_words_short_claim] => 22
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15891986
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/891986 | Potent and short promoter for expression of heterologous genes | Feb 7, 2018 | Issued |
Array
(
[id] => 18369311
[patent_doc_number] => 11649468
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-05-16
[patent_title] => Targeted integration into the PPP1R12C locus
[patent_app_type] => utility
[patent_app_number] => 15/880354
[patent_app_country] => US
[patent_app_date] => 2018-01-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 22
[patent_no_of_words] => 18959
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 109
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15880354
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/880354 | Targeted integration into the PPP1R12C locus | Jan 24, 2018 | Issued |
Array
(
[id] => 15294211
[patent_doc_number] => 20190390241
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-12-26
[patent_title] => VIRAL RESISTANT CELLS AND CULTURE SYSTEMS
[patent_app_type] => utility
[patent_app_number] => 16/480588
[patent_app_country] => US
[patent_app_date] => 2018-01-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17470
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -21
[patent_words_short_claim] => 38
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16480588
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/480588 | VIRAL RESISTANT CELLS AND CULTURE SYSTEMS | Jan 23, 2018 | Abandoned |
Array
(
[id] => 15267983
[patent_doc_number] => 20190382725
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-12-19
[patent_title] => SYSTEMS AND METHODS FOR IMMUNOMODULATION OF MUCOSAL-ASSOCIATED INVARIANT T CELLS
[patent_app_type] => utility
[patent_app_number] => 16/480273
[patent_app_country] => US
[patent_app_date] => 2018-01-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15061
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -72
[patent_words_short_claim] => 22
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16480273
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/480273 | Systems and methods for immunomodulation of mucosal-associated invariant T cells | Jan 22, 2018 | Issued |
Array
(
[id] => 13314201
[patent_doc_number] => 20180208637
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-07-26
[patent_title] => METHODS OF IDENTIFYING, ISOLATING AND USING ODORANT AND AROMA RECEPTORS
[patent_app_type] => utility
[patent_app_number] => 15/877215
[patent_app_country] => US
[patent_app_date] => 2018-01-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11338
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 149
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15877215
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/877215 | METHODS OF IDENTIFYING, ISOLATING AND USING ODORANT AND AROMA RECEPTORS | Jan 21, 2018 | Abandoned |
Array
(
[id] => 18187563
[patent_doc_number] => 11578132
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-02-14
[patent_title] => Method for producing B cell population and method for producing monoclonal antibody using same
[patent_app_type] => utility
[patent_app_number] => 16/478295
[patent_app_country] => US
[patent_app_date] => 2018-01-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 3
[patent_no_of_words] => 7920
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 98
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16478295
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/478295 | Method for producing B cell population and method for producing monoclonal antibody using same | Jan 14, 2018 | Issued |
Array
(
[id] => 18576715
[patent_doc_number] => 11733235
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-08-22
[patent_title] => Method for evaluating immunogenicity of test substance
[patent_app_type] => utility
[patent_app_number] => 16/471834
[patent_app_country] => US
[patent_app_date] => 2017-12-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 10173
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 78
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16471834
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/471834 | Method for evaluating immunogenicity of test substance | Dec 25, 2017 | Issued |
Array
(
[id] => 18620639
[patent_doc_number] => 11753667
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-09-12
[patent_title] => RNA-mediated gene assembly from DNA oligonucleotides
[patent_app_type] => utility
[patent_app_number] => 15/839104
[patent_app_country] => US
[patent_app_date] => 2017-12-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 26
[patent_figures_cnt] => 26
[patent_no_of_words] => 11579
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 192
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15839104
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/839104 | RNA-mediated gene assembly from DNA oligonucleotides | Dec 11, 2017 | Issued |